Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $93.72 million. The enterprise value is $262.40 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 52.50 million shares outstanding. The number of shares has increased by 29.85% in one year.
| Current Share Class | 52.50M |
| Shares Outstanding | 52.50M |
| Shares Change (YoY) | +29.85% |
| Shares Change (QoQ) | +1.68% |
| Owned by Insiders (%) | 2.57% |
| Owned by Institutions (%) | 44.36% |
| Float | 45.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| Forward PS | 0.43 |
| PB Ratio | 1.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 88.66 |
| P/OCF Ratio | 44.91 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 248.25 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.44.
| Current Ratio | 1.19 |
| Quick Ratio | 1.15 |
| Debt / Equity | 3.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | 208.82 |
| Interest Coverage | -6.83 |
Financial Efficiency
Return on equity (ROE) is -135.48% and return on invested capital (ROIC) is -10.96%.
| Return on Equity (ROE) | -135.48% |
| Return on Assets (ROA) | -8.78% |
| Return on Invested Capital (ROIC) | -10.96% |
| Return on Capital Employed (ROCE) | -27.78% |
| Revenue Per Employee | $600,414 |
| Profits Per Employee | -$392,756 |
| Employee Count | 454 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.62% in the last 52 weeks. The beta is 1.26, so Cardlytics's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -81.62% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 3.01 |
| Relative Strength Index (RSI) | 47.74 |
| Average Volume (20 Days) | 665,965 |
Short Selling Information
The latest short interest is 8.33 million, so 15.86% of the outstanding shares have been sold short.
| Short Interest | 8.33M |
| Short Previous Month | 8.37M |
| Short % of Shares Out | 15.86% |
| Short % of Float | 18.29% |
| Short Ratio (days to cover) | 7.92 |
Income Statement
In the last 12 months, Cardlytics had revenue of $272.59 million and -$178.31 million in losses. Loss per share was -$3.53.
| Revenue | 272.59M |
| Gross Profit | 115.16M |
| Operating Income | -65.89M |
| Pretax Income | -153.33M |
| Net Income | -178.31M |
| EBITDA | -40.16M |
| EBIT | -65.89M |
| Loss Per Share | -$3.53 |
Full Income StatementBalance Sheet
The company has $52.05 million in cash and $220.73 million in debt, giving a net cash position of -$168.68 million or -$3.21 per share.
| Cash & Cash Equivalents | 52.05M |
| Total Debt | 220.73M |
| Net Cash | -168.68M |
| Net Cash Per Share | -$3.21 |
| Equity (Book Value) | 64.09M |
| Book Value Per Share | 1.23 |
| Working Capital | 24.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.09 million and capital expenditures -$1.03 million, giving a free cash flow of $1.06 million.
| Operating Cash Flow | 2.09M |
| Capital Expenditures | -1.03M |
| Free Cash Flow | 1.06M |
| FCF Per Share | $0.02 |
Full Cash Flow StatementMargins
Gross margin is 42.25%, with operating and profit margins of -24.17% and -65.41%.
| Gross Margin | 42.25% |
| Operating Margin | -24.17% |
| Pretax Margin | -65.41% |
| Profit Margin | -65.41% |
| EBITDA Margin | -14.73% |
| EBIT Margin | -24.17% |
| FCF Margin | 0.39% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.85% |
| Shareholder Yield | -29.85% |
| Earnings Yield | -190.27% |
| FCF Yield | 1.13% |
Analyst Forecast
The average price target for Cardlytics is $3.50, which is 96.08% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.50 |
| Price Target Difference | 96.08% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -4.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.19 |
| Piotroski F-Score | 4 |